The Latest Breaking News from Cancer

BMO Capital initiated coverage of Intellia Therapeutics Inc (NASDAQ:NTLA) with a Market Perform rating and a $54 target price.  The analyst says Intellia's gene-editing platform could potentially deliver transformative therapies.  But challenges around the lack of clarity around an IND approval in the U.S., ongoing CRISPR/Cas9 IP litigations with Editas Medicine Inc (NASDAQ:EDIT), and high patient…

David Tennant's wife Georgia previously opened up about her experience having a cervical screening and then, later, a colposcopy

Exclusive: experts believe new form of photoimmunotherapy may become fifth major cancer treatment

The United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Kazia Therapeutics’ (NASDAQ: KZIA) Paxalisib for the treatment of atypical rhabdoid / teratoid tumors (AT/RT), a rare and highly-aggressive childhood brain cancer.

Abemaciclib is a twice-daily pill that is used with hormone therapy

The device has already been trialled on healthy patients in University Hospital Galway

The former Coronation Street actress was joined by dad Dave and mum Pauline on the BBC One show

Kym Marsh's father Dave, 77, was diagnosed with incurable prostate cancer after delaying getting a check-up during the pandemic

LAVA Therapeutics N.V. (NASDAQ:LVTX) hosted a clinical update call focused on initial Phase 1/2a data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) at the American Society of Clinical Oncology and European Hematology Association meetings. "Although preliminary, these data support our view of LAVA-051 as a promising candidate…